Rhinitis Allergy. Allergic rhinitis, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients with allergic rhinitis: Use of AllergyCut contains distilled plant product intended to remove symptoms of allergic rhinitis for 120 days with permissible d
Sponsors
MIM Daroo Pharmaceutical Co.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with Rhinitis after diagnosis by an immunologist or ENT physician Male and female patient who has symptoms of allergic rhinitis at least one month per year. A patient aged over 16 years old up to 60 years old who has the opportunity to complete the day care and has an effective relationship with the counselor. A patient who does not have allergy to herbal medicines.
Exclusion criteria
Exclusion criteria: Patient with rhinitis without diagnosis of immunological basis. Patients who do not want to start or continue treatment are not eligible for study. Patients who provide incomplete data to the counselor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduced Indicators Related to Rhinitis in Patients Consuming the Drugs. Timepoint: Drug intakes for 60 to 120 days. Method of measurement: Study of allergy-related rhinitis allergy indexes under the supervision of an immunologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarid Semsarha
MIM Daroo
Outcome results
None listed